Fund HoldingsTCG Crossover Management, LLC

Total Portfolio Value
$1.18B
Total Bought
$206.62M
Total Sold
$131.03M
Net Transaction
+$75.59M
Filing Period:
Securities
SharesValue ($K)
Q2 2024
Q3 2024
Change
Q2 2024
Q3 2024
Weight (%)
Change
XENCOR INC(XNCR)02,427,138+2,427,138048,8104.14%+48,810
THIRD HARMONIC BIO INC02,415,000+2,415,000032,7232.77%+32,723
SOLENO THERAPEUTIVS, INC.0550,000+550,000027,7702.35%+27,770
CG ONCOLOGY, INC.(CGON)3,670,2063,670,2060115,868138,47711.73%+22,608
CENTESSA PHARMACEUTICALS PLC2,890,8162,890,816026,10446,2243.92%+20,120
STRUCTURE THERAPEUTICS INC694,5471,063,000+368,45327,27546,6553.95%+19,380
TOURMALINE BIO INC1,477,5931,477,593019,00237,9893.22%+18,987
FULCRUM THERAPEUTICS INC05,250,000+5,250,000018,7431.59%+18,743
MBX BIOSCIENCES INC(MBX)0650,000+650,000016,8871.43%+16,887
COGENT BIOSCIENCES INC(COGT)6,964,3756,964,375058,71075,2156.37%+16,506
EDGEWISE THERAPEUTICS, INC.(EWTX)2,272,7282,112,984-159,74440,93256,3964.78%+15,464
AMYLYX PHARMACEUTICALS INC(AMLX)04,643,812+4,643,812015,0461.27%+15,046
TYRA BIOSCIENCES INC(TYRA)1,989,1031,989,103031,80646,7643.96%+14,958
ADVERUM BIOTECHNOLOGIES, INC.02,008,339+2,008,339014,0991.19%+14,099
KEROS THERAPEUTICS, INC.879,344879,344040,18651,0644.33%+10,877
OCULAR THERAPEUTIX, INC.(OCUL)5,319,1485,319,148036,38346,2773.92%+9,894
VISTAGEN THERAPEUTICS INC02,676,580+2,676,58008,0570.68%+8,057
ASTRIA THERAPEUTICS, INC.2,761,8612,761,861025,13330,4082.58%+5,275
AVALO THERAPEUTICS INC(AVTX)0483,000+483,00004,5890.39%+4,589
SAVARA INC.(SVRA)12,362,20512,362,205049,82052,4164.44%+2,596
Disc Medicine, Inc.(IRON)486,957486,957021,94723,9292.03%+1,982
DYNE THERAPEUTICS, INC(DYN)2,650,1502,650,150093,52495,1938.07%+1,670
ENTRADA THERAPEUTICS INC584,955584,95508,3369,3480.79%+1,012
COMPASS PATHWAYS PLC(CMPS)3,858,0003,858,000023,30224,3052.06%+1,003
AEROVATE THERAPEUTICS INC2,240,8092,240,80903,7204,6830.40%+964
KODIAK SCIENCES INC(KOD)899,9991,008,158+108,1592,1152,6310.22%+516
NEKTAR THERAPEUTICS(NKTR)4,000,0004,000,00004,9605,2000.44%+240
VENTYX BIOSCIENCES, INC316,195316,19507306890.06%-41
CABALETTA BIO, INC86,79586,79506494100.03%-240
EyePoint Pharmaceuticals, Inc.(EYPT)922,335922,33508,0247,3690.62%-655
KURA ONCOLOGY INC(KURA)1,423,6421,423,642029,31327,8182.36%-1,495
AN2 Therapeutics, Inc.1,555,1181,555,11803,3441,6640.14%-1,680
C4 THERAPEUTICS, INC.1,276,5740-1,276,5745,8980-5,898
MINERALYS THERAPEUTICS, INC.(MLYS)3,185,1852,470,265-714,92037,26729,9152.53%-7,352
SILENCE THERAPEUTICS PLC3,295,3503,033,560-261,79062,61255,1504.67%-7,462
TARSUS PHARMACEUTICALS, INC.(TARS)556,317231,820-324,49715,1217,6250.65%-7,496
VISTAGEN THERAPEUTICS INC2,676,5800-2,676,5809,3140-9,314
Abivax SA(ABVX)6,056,5966,056,596080,06869,7725.91%-10,296
ADVERUM BIOTECHNOLOGIES, INC.2,008,3400-2,008,34013,7770-13,777
SOLENO THERAPEUTIVS, INC.550,0000-550,00022,4400-22,440
MADRIGAL PHARMACEUTICALS INC(MDGL)149,2830-149,28341,8230-41,823
Page 1 of 1